Reuters logo
BRIEF-Merck announces U.S. FDA grants tentative approval for Lusduna™ Nexvue™
July 20, 2017 / 11:50 AM / 2 months ago

BRIEF-Merck announces U.S. FDA grants tentative approval for Lusduna™ Nexvue™

July 20 (Reuters) - Merck & Co Inc

* Merck announces U.S. FDA grants tentative approval for Lusduna™ Nexvue™ (insulin glargine injection), a follow-on biologic basal insulin

* Says trade name “lusduna nexvue” was granted provisional approval by FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below